tiprankstipranks
Trending News
More News >
ReShape Lifesciences (RSLS)
NASDAQ:RSLS
Advertisement

ReShape Lifesciences (RSLS) Revenue

Compare
583 Followers

ReShape Lifesciences Revenue

ReShape Lifesciences had a revenue of 1.11M in the quarter ending Mar 31, 2025, with -38.34%. This bring the company's revenue in the last twelve months to 7.17M, Increased -10.38%. In the fiscal year ending Dec 31, 2024, ReShape Lifesciences had annual revenue of 8.01M with -7.74% growth.
Revenue (ttm)
7.17M
Revenue Growth
-7.74%
P/S Ratio
0.90
Revenue/Employee
$470,941
Employees
17
Market Cap
$7.21M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
8.01M-672.00K-7.74%
Dec 31, 2023
8.68M-2.56M-22.79%
Dec 31, 2022
11.24M-2.36M-17.35%
Dec 31, 2021
13.60M2.30M+20.36%
Dec 31, 2020
11.30M-3.79M-25.12%
Dec 31, 2019
15.09M14.48M+2,387.02%
Dec 31, 2018
606.71K-680.44K-52.86%
Dec 31, 2017
1.29M500.49K+63.62%
Dec 31, 2016
786.66K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis